An update on the use of NOD mice to study autoimmune (Type 1) diabetes

References

• Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp. Anim.29(1), 11–13 (1980).
   Google Scholar
• Shoda LK, Young DL, Ramanujan S et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity23(2), 115–126 (2005).
   PubMed Web of Science ®Google Scholar
• Suri A, Walters JJ, Gross ML, Unanue ER. Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificity. J. Clin. Invest.115(8), 2268–2276 (2005).
   PubMed Web of Science ®Google Scholar
• Wang J, Wicker LS, Santamaria P. IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity. Semin. Immunol.21(6), 363–371 (2009).
   PubMed Web of Science ®Google Scholar
• Lieberman SM, Evans AM, Han B et al. Identification of the b cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl Acad. Sci. USA100(14), 8384–8388 (2003).
   PubMed Web of Science ®Google Scholar
• Jarchum I, Nichol L, Trucco M, Santamaria P, DiLorenzo TP. Identification of novel IGRP epitopes targeted in Type 1 diabetes patients. Clin. Immunol.127(3), 359–365 (2008).
   PubMed Web of Science ®Google Scholar
• Mallone R, Martinuzzi E, Blancou P et al. CD8+ T-cell responses identify βcell autoimmunity in human Type 1 diabetes. Diabetes56(3), 613–621 (2007).
   PubMed Web of Science ®Google Scholar
• Standifer NE, Ouyang Q, Panagiotopoulos C et al. Identification of novel HLA-A*0201-restricted epitopes in recent-onset Type 1 diabetic subjects and antibody-positive relatives. Diabetes55(11), 3061–3067 (2006).
   PubMed Web of Science ®Google Scholar
• Hanna J, Markoulaki S, Mitalipova M et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell4(6), 513–524 (2009).
   PubMed Web of Science ®Google Scholar
• Nichols J, Jones K, Phillips JM et al. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat. Med.15(7), 814–818 (2009).
   PubMed Web of Science ®Google Scholar
• Jarchum I, DiLorenzo TP. Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin. J. Immunol.185(2), 658–665 (2010).
   Google Scholar
• Takaki T, Marron MP, Mathews CE et al. HLA-A*0201-restricted T cells from ‘humanized’ NOD mice recognize autoantigens of potential clinical relevance to Type 1 diabetes. J. Immunol.176(5), 3257–3265 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang L, Nakayama M, Eisenbarth GS. Insulin as an autoantigen in NOD/human diabetes. Curr. Opin. Immunol.20(1), 111–118 (2008).
   PubMed Web of Science ®Google Scholar
• Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol.25(4), 1056–1062 (1995).
   PubMed Web of Science ®Google Scholar
• Wong FS, Karttunen J, Dumont C et al. Identification of an MHC class I-restricted autoantigen in Type 1 diabetes by screening an organ-specific cDNA library. Nat. Med.5(9), 1026–1031 (1999).
   PubMed Web of Science ®Google Scholar
• Nakayama M, Abiru N, Moriyama H et al. Prime role for an insulin epitope in the development of Type 1 diabetes in NOD mice. Nature435(7039), 220–223 (2005).
   PubMed Web of Science ®Google Scholar
• Krishnamurthy B, Dudek NL, McKenzie MD et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest.116(12), 3258–3265 (2006).
   PubMed Web of Science ®Google Scholar
• Fife BT, Guleria I, Gubbels Bupp M et al. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway. J. Exp. Med.203(12), 2737–2747 (2006).
   PubMed Web of Science ®Google Scholar
• Levisetti MG, Suri A, Petzold SJ, Unanue ER. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J. Immunol.178(10), 6051–6057 (2007).
   PubMed Web of Science ®Google Scholar
• Mohan JF, Levisetti MG, Calderon B, Herzog JW, Petzold SJ, Unanue ER. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat. Immunol.11(4), 350–354 (2010).
   PubMed Web of Science ®Google Scholar
• Stadinski BD, Delong T, Reisdorph N et al. Chromogranin A is an autoantigen in Type 1 diabetes. Nat. Immunol.11(3), 225–231 (2010).
   PubMed Web of Science ®Google Scholar
• Stadinski B, Kappler J, Eisenbarth GS. Molecular targeting of islet autoantigens. Immunity32(4), 446–456 (2010).
   PubMed Web of Science ®Google Scholar
• Burton AR, Vincent E, Arnold PY et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes57(5), 1321–1330 (2008).
   PubMed Web of Science ®Google Scholar
• Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv. Immunol.87, 123–162 (2005).
   PubMed Web of Science ®Google Scholar
• Drexler K, Burtles S, Hurtenbach U. Limited heterogeneity of T-cell receptor Vb gene expression in the early stage of insulitis in NOD mice. Immunol. Lett.37(2–3), 187–196 (1993).
   PubMed Web of Science ®Google Scholar
• Lennon GP, Bettini M, Burton AR et al. T cell islet accumulation in Type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity31(4), 643–653 (2009).
   PubMed Web of Science ®Google Scholar
• Lieberman SM, Takaki T, Han B, Santamaria P, Serreze DV, DiLorenzo TP. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol.173(11), 6727–6734 (2004).
   PubMed Web of Science ®Google Scholar
• Wenzlau JM, Juhl K, Yu L et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human Type 1 diabetes. Proc. Natl Acad. Sci. USA104(43), 17040–17045 (2007).
   PubMed Web of Science ®Google Scholar
• Li SW, Koya V, Li Y et al. Pancreatic duodenal homeobox 1 protein is a novel βcell-specific autoantigen for type I diabetes. Lab. Invest.90(1), 31–39 (2010).
   PubMed Web of Science ®Google Scholar
• Winer S, Tsui H, Lau A et al. Autoimmune islet destruction in spontaneous Type 1 diabetes is not βcell exclusive. Nat. Med.9(2), 198–205 (2003).
   PubMed Web of Science ®Google Scholar
• Driver JP, Serreze DV, Chen YG. Mouse models for the study of autoimmune Type 1 diabetes: a NOD to similarities and differences to human disease. Semin. Immunopathol. DOI: 10.1007/s00281-010-0204-1 (Epub ahead of print) (2010).
   PubMedGoogle Scholar
• Araki M, Chung D, Liu S et al. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 Type 1 diabetes region in nonobese diabetic mice. J. Immunol. 183(8), 5146–5157 (2009).
   Google Scholar
• Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature423(6939), 506–511 (2003).
   PubMed Web of Science ®Google Scholar
• Vijayakrishnan L, Slavik JM, Illes Z et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity20(5), 563–575 (2004).
   PubMed Web of Science ®Google Scholar
• Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ. A native soluble form of CTLA-4. Cell. Immunol.201(2), 144–153 (2000).
   PubMed Web of Science ®Google Scholar
• Yamanouchi J, Rainbow D, Serra P et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet.39(3), 329–337 (2007).
   PubMed Web of Science ®Google Scholar
• Lowe CE, Cooper JD, Brusko T et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in Type 1 diabetes. Nat. Genet.39(9), 1074–1082 (2007).
   PubMed Web of Science ®Google Scholar
• Vella A, Cooper JD, Lowe CE et al. Localization of a Type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet.76(5), 773–779 (2005).
   PubMed Web of Science ®Google Scholar
• Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest.109(1), 131–140 (2002).
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4+CD25+ T-cells from patients with Type 1 diabetes. Diabetes54(1), 92–99 (2005).
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Signore A, Williams AJ, Beales PE. NOD mouse colonies around the world – recent facts and figures. Immunol. Today14(5), 193–196 (1993).
   PubMedGoogle Scholar
• Ohsugi T, Kurosawa T. Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. Lab. Anim. Sci.44(4), 386–388 (1994).
   PubMedGoogle Scholar
• Cooke A, Tonks P, Jones FM et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol.21(4), 169–176 (1999).
   PubMed Web of Science ®Google Scholar
• Bras A, Aguas AP. Diabetes-prone NOD mice are resistant to Mycobacterium aviumand the infection prevents autoimmune disease. Immunology89(1), 20–25 (1996).
   PubMed Web of Science ®Google Scholar
• Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune Type 1 diabetes by gastrointestinal helminth infection. Infect. Immun.75(1), 397–407 (2007).
   PubMed Web of Science ®Google Scholar
• Raine T, Zaccone P, Mastroeni P, Cooke A. Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent Type 1 diabetes. J. Immunol. 177(4), 2224–2233 (2006).
   Google Scholar
• Cooke A. Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of Type 1 diabetes?. Immunology126(1), 12–17 (2009).
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature455(7216), 1109–1113 (2008).
   PubMed Web of Science ®Google Scholar
• Calcinaro F, Dionisi S, Marinaro M et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia48(8), 1565–1575 (2005).
   PubMed Web of Science ®Google Scholar
• Karumuthil-Melethil S, Perez N, Li R, Vasu C. Induction of innate immune response through TLR2 and dectin 1 prevents Type 1 diabetes. J. Immunol.181(12), 8323–8334 (2008).
   PubMed Web of Science ®Google Scholar
• Staeva-Vieira T, Peakman M, von Herrath M. Translational mini-review series on Type 1 diabetes: immune-based therapeutic approaches for Type 1 diabetes. Clin. Exp. Immunol.148(1), 17–31 (2007).
   PubMed Web of Science ®Google Scholar
• Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J. Immunol.172(5), 2731–2738 (2004).
   PubMed Web of Science ®Google Scholar
• Chatenoud L, Thervet E, Primo J, Bach JF. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl Acad. Sci. USA91(1), 123–127 (1994).
   PubMed Web of Science ®Google Scholar
• Herold KC, Gitelman SE, Masharani U et al. A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of Type 1 diabetes. Diabetes54(6), 1763–1769 (2005).
   PubMed Web of Science ®Google Scholar
• Keymeulen B, Vandemeulebroucke E, Ziegler AG et al. Insulin needs after CD3-antibody therapy in new-onset Type 1 diabetes. N. Engl. J. Med.352(25), 2598–2608 (2005).
   PubMed Web of Science ®Google Scholar
• Hu CY, Rodriguez-Pinto D, Du W et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest.117(12), 3857–3867 (2007).
   PubMed Web of Science ®Google Scholar
• Xiu Y, Wong CP, Bouaziz JD et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcgR effector functions. J. Immunol.180(5), 2863–2875 (2008).
   PubMed Web of Science ®Google Scholar
• Zekavat G, Rostami SY, Badkerhanian A et al.In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J. Immunol.181(11), 8133–8144 (2008).
   PubMed Web of Science ®Google Scholar
• Marino E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST. CD4+CD25+ T-cells control autoimmunity in the absence of B-cells. Diabetes58(7), 1568–1577 (2009).
   PubMed Web of Science ®Google Scholar
• Fiorina P, Vergani A, Dada S et al. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes57(11), 3013–3024 (2008).
   PubMed Web of Science ®Google Scholar
• Serreze DV, Chapman HD, Varnum DS et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new ‘speed congenic’ stock of NOD.Igµnull mice. J. Exp. Med.184(5), 2049–2053 (1996).
   PubMed Web of Science ®Google Scholar
• Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol.161(8), 3912–3918 (1998).
   PubMed Web of Science ®Google Scholar
• Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al. Rituximab, B-lymphocyte depletion, and preservation of βcell function. N. Engl. J. Med.361(22), 2143–2152 (2009).
   PubMed Web of Science ®Google Scholar
• Bresson D, Togher L, Rodrigo E et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest.116(5), 1371–1381 (2006).
   PubMed Web of Science ®Google Scholar
• Sherry NA, Chen W, Kushner JA et al. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of βcells. Endocrinology148(11), 5136–5144 (2007).
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen M, Carter JD et al. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes. Biochem. Biophys. Res. Commun.344(3), 1017–1022 (2006).
   PubMed Web of Science ®Google Scholar
• Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A. Combination therapy with epidermal growth factor and gastrin increases βcell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes54(9), 2596–2601 (2005).
   PubMed Web of Science ®Google Scholar
• Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes57(12), 3281–3288 (2008).
   PubMed Web of Science ®Google Scholar
• Suarez-Pinzon WL, Cembrowski GS, Rabinovitch A. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia52(8), 1680–1682 (2009).
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in Type 1 diabetes. Nature464(7293), 1293–1300 (2010).
   PubMed Web of Science ®Google Scholar
• Datta S, Sarvetnick NE. IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS One3(9), e3118 (2008).
   PubMedGoogle Scholar
• Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. IL-21 signaling is critical for the development of Type I diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA105(37), 14028–14033 (2008).
   PubMed Web of Science ®Google Scholar
• Sutherland AP, Van Belle T, Wurster AL et al. Interleukin-21 is required for the development of Type 1 diabetes in NOD mice. Diabetes58(5), 1144–1155 (2009).
   PubMed Web of Science ®Google Scholar
• Emamaullee JA, Davis J, Merani S et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes58(6), 1302–1311 (2009).
   PubMed Web of Science ®Google Scholar
• You S, Poulton L, Cobbold S et al. Key role of the GITR/GITR ligand pathway in the development of murine autoimmune diabetes: a potential therapeutic target. PLoS One4(11), e7848 (2009).
   PubMed Web of Science ®Google Scholar
• Hawiger D, Tran E, Du W et al. ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice. J. Immunol.180(5), 3140–3147 (2008).
   PubMed Web of Science ®Google Scholar
• Billotey C, Aspord C, Beuf O et al. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging. Radiology236(2), 579–587 (2005).
   PubMed Web of Science ®Google Scholar
• Medarova Z, Tsai S, Evgenov N, Santamaria P, Moore A. In vivo imaging of a diabetogenic CD8+ T cell response during Type 1 diabetes progression. Magn. Reson. Med. 59(4), 712–720 (2008).
   Google Scholar
• Turvey SE, Swart E, Denis MC et al. Noninvasive imaging of pancreatic inflammation and its reversal in Type 1 diabetes. J. Clin. Invest.115(9), 2454–2461 (2005).
   PubMed Web of Science ®Google Scholar
• Medarova Z, Bonner-Weir S, Lipes M, Moore A. Imaging βcell death with a near-infrared probe. Diabetes54(6), 1780–1788 (2005).
   PubMed Web of Science ®Google Scholar
• Martinuzzi E, Novelli G, Scotto M et al. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after Type 1 diabetes diagnosis and treatment. Diabetes57(5), 1312–1320 (2008).
   PubMed Web of Science ®Google Scholar
• Ouyang Q, Standifer NE, Qin H et al. Recognition of HLA class I-restricted βcell epitopes in Type 1 diabetes. Diabetes55(11), 3068–3074 (2006).
   PubMed Web of Science ®Google Scholar
• Pinkse GG, Tysma OH, Bergen CA et al. Autoreactive CD8 T cells associated with b cell destruction in Type 1 diabetes. Proc. Natl Acad. Sci. USA102(51), 18425–18430 (2005).
   PubMed Web of Science ®Google Scholar
• Toma A, Haddouk S, Briand JP et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in Type 1 diabetic patients. Proc. Natl Acad. Sci. USA102(30), 10581–10586 (2005).
   PubMed Web of Science ®Google Scholar
• Unger WW, Pinkse GG, Mulder-van der Kracht S et al. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men. Ann. NY Acad. Sci.1103, 192–195 (2007).
   PubMed Web of Science ®Google Scholar
• Jarchum I, Baker JC, Yamada T et al.In vivo cytotoxicity of insulin-specific CD8+ T cells in HLA-A*0201-transgenic NOD mice. Diabetes56(10), 2551–2560 (2007).
   PubMed Web of Science ®Google Scholar
• Kanagawa O, Xu G, Tevaarwerk A, Vaupel BA. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-γ receptor loci. J. Immunol.164(7), 3919–3923 (2000).
   PubMed Web of Science ®Google Scholar
• Leiter EH, Reifsnyder PC, Wallace R, Li R, King B, Churchill GC. NOD x 129.H2g7 backcross delineates 129S1/SvImJ-derived genomic regions modulating Type 1 diabetes development in mice. Diabetes58(7), 1700–1703 (2009).
   PubMed Web of Science ®Google Scholar
• Steward CA, Humphray S, Plumb B et al. Genome-wide end-sequenced BAC resources for the NOD/MrkTac and NOD/ShiLtJ mouse genomes. Genomics95(2), 105–110 (2010).
   PubMed Web of Science ®Google Scholar
• Fennessy M, Metcalfe K, Hitman GA et al. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia37(9), 937–944 (1994).
   PubMed Web of Science ®Google Scholar
• Nejentsev S, Howson JM, Walker NM et al. Localization of Type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.Nature450(7171), 887–892 (2007).
   PubMed Web of Science ®Google Scholar
• Robles DT, Eisenbarth GS, Wang T et al. Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin. Immunol.102(3), 217–224 (2002).
   PubMed Web of Science ®Google Scholar
• Enee E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice. J. Immunol.180(8), 5430–5438 (2008).
   PubMed Web of Science ®Google Scholar
• Pugliese A, Zeller M, Fernandez A Jr et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for Type 1 diabetes. Nat. Genet.15(3), 293–297 (1997).
   PubMed Web of Science ®Google Scholar
• Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet.15(3), 289–292 (1997).
   PubMed Web of Science ®Google Scholar
• van Halteren AG, Kardol MJ, Mulder A, Roep BO. Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia48(1), 75–82 (2005).
   PubMed Web of Science ®Google Scholar
• King M, Pearson T, Shultz LD et al. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor γ chain gene. Clin. Immunol.126(3), 303–314 (2008).
   PubMed Web of Science ®Google Scholar
• Brehm MA, Cuthbert A, Yang C et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rIL2rγnull mutation. Clin. Immunol.135(1), 84–98 (2010).
   PubMed Web of Science ®Google Scholar
• Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science222(4630), 1337–1339 (1983).
   PubMed Web of Science ®Google Scholar
• Rudy G, Stone N, Harrison LC et al. Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med.1(6), 625–633 (1995).
   PubMed Web of Science ®Google Scholar
• Pontesilli O, Carotenuto P, Gazda LS, Pratt PF, Prowse SJ. Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol.70(1), 84–93 (1987).
   PubMed Web of Science ®Google Scholar
• Wegmann DR, Norbury-Glaser M, Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol.24(8), 1853–1857 (1994).
   PubMed Web of Science ®Google Scholar
• Gillard BK, Thomas JW, Nell LJ, Marcus DM. Antibodies against ganglioside GT3 in the sera of patients with Type I diabetes mellitus. J. Immunol.142(11), 3826–3832 (1989).
   PubMed Web of Science ®Google Scholar
• Ozawa Y, Kasuga A, Nomaguchi H et al. Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus. J. Autoimmun.9(4), 517–524 (1996).
   PubMed Web of Science ®Google Scholar
• Abulafia-Lapid R, Elias D, Raz I, Keren-Zur Y, Atlan H, Cohen IR. T cell proliferative responses of Type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun.12(2), 121–129 (1999).
   PubMed Web of Science ®Google Scholar
• Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl Acad. Sci. USA87(4), 1576–1580 (1990).
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature347(6289), 151–156 (1990).
   PubMed Web of Science ®Google Scholar
• DeAizpurua HJ, Honeyman MC, Harrison LC. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J. Autoimmun.5(6), 759–770 (1992).
   PubMed Web of Science ®Google Scholar
• Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature366(6450), 72–75 (1993).
   PubMed Web of Science ®Google Scholar
• Clark A, Yon SM, de Koning EJ, Holman RR. Autoantibodies to islet amyloid polypeptide in diabetes. Diabet. Med.8(7), 668–673 (1991).
   PubMed Web of Science ®Google Scholar
• Panagiotopoulos C, Qin H, Tan R, Verchere CB. Identification of a βcell-specific HLA class I restricted epitope in Type 1 diabetes. Diabetes52(11), 2647–2651 (2003).
   PubMed Web of Science ®Google Scholar
• Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J. Clin. Endocrinol. Metab.73(6), 1197–1201 (1991).
   PubMed Web of Science ®Google Scholar
• Yang L, Zhou Z, Du T, Tan S, Zhnag Y, Jin P. [Detection of carboxypeptidase H specific T cells in peripheral blood of latent autoimmune diabetic patients with carboxypeptidase antibody positivity by ELISPOT assay]. Zhong Nan Da Xue Xue Bao Yi Xue Ban34(10), 1011–1016 (2009).
   PubMedGoogle Scholar
• Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes41(2), 183–186 (1992).
   PubMed Web of Science ®Google Scholar
• Durinovic-Bello I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes45(6), 795–800 (1996).
   PubMedGoogle Scholar
• Trembleau S, Penna G, Gregori S, Magistrelli G, Isacchi A, Adorini L. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in Type 1 diabetes. J. Immunol.165(12), 6748–6755 (2000).
   PubMed Web of Science ®Google Scholar
• Inman LR, McAllister CT, Chen L et al. Autoantibodies to the GLUT-2 glucose transporter of b cells in insulin-dependent diabetes mellitus of recent onset. Proc. Natl Acad. Sci. USA90(4), 1281–1284 (1993).
   PubMed Web of Science ®Google Scholar
• Monetini L, Barone F, Stefanini L et al. Establishment of T cell lines to bovine βcasein and βcasein-derived epitopes in patients with Type 1 diabetes. J. Endocrinol.176(1), 143–150 (2003).
   PubMed Web of Science ®Google Scholar
• Liddi R, Beales PE, Rosignoli G, Pozzilli P. Incomplete Freund’s adjuvant reduces diabetes in the non-obese diabetic mouse. Horm. Metab. Res.32(6), 201–206 (2000).
   PubMed Web of Science ®Google Scholar
• Honeyman MC, Cram DS, Harrison LC. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes42(4), 626–630 (1993).
   PubMed Web of Science ®Google Scholar
• Hagopian WA, Michelsen B, Karlsen AE et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes42(4), 631–636 (1993).
   PubMed Web of Science ®Google Scholar
• Honeyman MC, Cram DS, Harrison LC. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J. Exp. Med.177(2), 535–540 (1993).
   PubMed Web of Science ®Google Scholar
• Elliott JF, Qin HY, Bhatti S et al. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes43(12), 1494–1499 (1994).
   PubMed Web of Science ®Google Scholar
• Pietropaolo M, Castano L, Babu S et al. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest.92(1), 359–371 (1993).
   PubMed Web of Science ®Google Scholar
• Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol.26(6), 1285–1289 (1996).
   PubMed Web of Science ®Google Scholar
• Karges W, Hammond-McKibben D, Cheung RK et al. Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow’s milk-based IDDM prevention trial. Diabetes46(4), 557–564 (1997).
   PubMed Web of Science ®Google Scholar
• Buschard K, Josefsen K, Horn T, Fredman P. Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet342(8875), 840 (1993).
   PubMed Web of Science ®Google Scholar
• Tiberti C, Dotta F, Anastasi E et al. Anti-ganglioside antibodies in new onset Type 1 diabetic patients and high risk subjects. Autoimmunity22(1), 43–48 (1995).
   PubMed Web of Science ®Google Scholar
• Arden SD, Roep BO, Neophytou PI et al. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed Type 1 diabetic patient. J. Clin. Invest.97(2), 551–561 (1996).
   PubMed Web of Science ®Google Scholar
• Chang YH, Hwang J, Shang HF, Tsai ST. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes45(4), 408–414 (1996).
   PubMedGoogle Scholar
• Aanstoot HJ, Kang SM, Kim J et al. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in Type 1 diabetes. J. Clin. Invest.97(12), 2772–2783 (1996).
   PubMed Web of Science ®Google Scholar
• Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes45(9), 1187–1192 (1996).
   PubMed Web of Science ®Google Scholar
• Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 b) in human prediabetes. J. Immunol.172(6), 3955–3962 (2004).
   PubMed Web of Science ®Google Scholar
• Kelemen K, Crawford ML, Gill RG, Hutton JC, Wegmann D. Cellular immune response to phogrin in the NOD mouse: cloned T-cells cause destruction of islet transplants. Diabetes48(8), 1529–1534 (1999).
   PubMed Web of Science ®Google Scholar
• Dotta F, Gianani R, Previti M et al. Autoimmunity to the GM2–1 islet ganglioside before and at the onset of Type I diabetes. Diabetes45(9), 1193–1196 (1996).
   PubMed Web of Science ®Google Scholar
• Fierabracci A, Biro PA, Yiangou Y et al. Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus. Vaccine18(3–4), 342–354 (1999).
   PubMed Web of Science ®Google Scholar
• Pupilli C, Giannini S, Marchetti P et al. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes48(12), 2309–2315 (1999).
   PubMed Web of Science ®Google Scholar
• Kasimiotis H, Myers MA, Argentaro A et al. Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes49(4), 555–561 (2000).
   PubMed Web of Science ®Google Scholar
• Gurr W, Yavari R, Wen L et al. A Reg family protein is overexpressed in islets from a patient with new-onset Type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes51(2), 339–346 (2002).
   PubMed Web of Science ®Google Scholar
• Qin HY, Mahon JL, Atkinson MA, Chaturvedi P, Lee-Chan E, Singh B. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J. Autoimmun.20(3), 237–245 (2003).
   PubMed Web of Science ®Google Scholar
• Abulafia-Lapid R, Gillis D, Yosef O, Atlan H, Cohen IR. T cells and autoantibodies to human HSP70 in Type 1 diabetes in children. J. Autoimmun.20(4), 313–321 (2003).
   PubMed Web of Science ®Google Scholar
• Yang J, Danke NA, Berger D et al. Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J. Immunol.176(5), 2781–2789 (2006).
   PubMed Web of Science ®Google Scholar
• Shervani NJ, Takasawa S, Uchigata Y et al. Autoantibodies to REG, a βcell regeneration factor, in diabetic patients. Eur. J. Clin. Invest.34(11), 752–758 (2004).
   PubMed Web of Science ®Google Scholar
• Ola TO, Biro PA, Hawa MI et al. Importin b: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage. J. Autoimmun.26(3), 197–207 (2006).
   PubMed Web of Science ®Google Scholar
• Gurr W, Shaw M, Li Y, Sherwin R. RegII is a βcell protein and autoantigen in diabetes of NOD mice. Diabetes56(1), 34–40 (2007).
   PubMed Web of Science ®Google Scholar
• Hardt PD, Ewald N, Brockling K et al. Distinct autoantibodies against exocrine pancreatic antigens in European patients with Type 1 diabetes mellitus and non-alcoholic chronic pancreatitis. JOP9(6), 683–689 (2008).
   PubMedGoogle Scholar
• Endo T, Takizawa S, Tanaka S et al. Amylase α-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant Type 1 diabetes. Diabetes58(3), 732–737 (2009).
   PubMed Web of Science ®Google Scholar
• Takizawa S, Endo T, Wanjia X, Tanaka S, Takahashi M, Kobayashi T. HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant Type 1 diabetes. Biochem. Biophys. Res. Commun.386(1), 192–196 (2009).
   PubMed Web of Science ®Google Scholar
• Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T-cells. Diabetes54(1), 78–84 (2005).
   PubMed Web of Science ®Google Scholar
• Steptoe RJ, Ritchie JM, Jones LK, Harrison LC. Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Diabetes54(2), 434–442 (2005).
   PubMed Web of Science ®Google Scholar
• Maki T, Gottschalk R, Ogawa N, Monaco AP. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. Transplantation79(9), 1051–1055 (2005).
   PubMed Web of Science ®Google Scholar
• Han B, Serra P, Amrani A et al. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med.11(6), 645–652 (2005).
   PubMed Web of Science ®Google Scholar
• Huang CC, Lu YF, Wen SN et al. A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases. Eur. J. Immunol.35(7), 2239–2249 (2005).
   PubMed Web of Science ®Google Scholar
• Olcott AP, Tian J, Walker V et al. Antigen-based therapies using ignored determinants of b cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice. J. Immunol.175(3), 1991–1999 (2005).
   PubMed Web of Science ®Google Scholar
• Shigihara T, Shimada A, Oikawa Y et al. CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced b cell proliferation in NOD mice. J. Immunol.175(12), 8401–8408 (2005).
   PubMed Web of Science ®Google Scholar
• Medicherla S, Protter AA, Ma JY et al. Preventive and therapeutic potential of p38α-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with Type 1 diabetes. J. Pharmacol. Exp. Ther.318(1), 99–107 (2006).
   PubMed Web of Science ®Google Scholar
• Tarbell KV, Petit L, Zuo X et al. Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med.204(1), 191–201 (2007).
   PubMed Web of Science ®Google Scholar
• Meagher C, Arreaza G, Peters A et al. CCL4 protects from Type 1 diabetes by altering islet βcell-targeted inflammatory responses. Diabetes56(3), 809–817 (2007).
   PubMed Web of Science ®Google Scholar
• Stosic-Grujicic S, Cvetkovic I, Mangano K et al. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice. J. Pharmacol. Exp. Ther.320(3), 1038–1049 (2007).
   PubMed Web of Science ®Google Scholar
• Chang CL, Chang SL, Lee YM et al. Cytopiloyne, a polyacetylenic glucoside, prevents Type 1 diabetes in nonobese diabetic mice. J. Immunol.178(11), 6984–6993 (2007).
   PubMed Web of Science ®Google Scholar
• Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Transfusion of apoptotic βcells induces immune tolerance to βcell antigens and prevents Type 1 diabetes in NOD mice. Diabetes56(8), 2116–2123 (2007).
   PubMed Web of Science ®Google Scholar
• Gaudreau S, Guindi C, Menard M, Besin G, Dupuis G, Amrani A. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J. Immunol.179(6), 3638–3647 (2007).
   PubMed Web of Science ®Google Scholar
• Phillips B, Nylander K, Harnaha J et al. A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes. Diabetes57(6), 1544–1555 (2008).
   PubMed Web of Science ®Google Scholar
• Bitan M, Weiss L, Zeira M et al. Heparanase prevents the development of Type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production. Diabetes Metab. Res. Rev.24(5), 413–421 (2008).
   PubMed Web of Science ®Google Scholar
• Besin G, Gaudreau S, Menard M, Guindi C, Dupuis G, Amrani A. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes. Diabetes57(8), 2107–2117 (2008).
   PubMed Web of Science ®Google Scholar
• Mabley JG, Pacher P, Murthy KG et al. The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of Type I diabetes. J. Endocrinol.198(3), 581–589 (2008).
   PubMed Web of Science ®Google Scholar
• Goudy KS, Wang B, Tisch R. Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of Type 1 diabetes in nonobese diabetic mice. Clin. Immunol.129(1), 49–57 (2008).
   PubMed Web of Science ®Google Scholar
• Louvet C, Szot GL, Lang J et al. Tyrosine kinase inhibitors reverse Type 1 diabetes in nonobese diabetic mice. Proc. Natl Acad. Sci. USA105(48), 18895–18900 (2008).
   PubMed Web of Science ®Google Scholar
• Perone MJ, Bertera S, Shufesky WJ et al. Suppression of autoimmune diabetes by soluble galectin-1. J. Immunol.182(5), 2641–2653 (2009).
   PubMed Web of Science ®Google Scholar
• Madec AM, Mallone R, Afonso G et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia52(7), 1391–1399 (2009).
   PubMed Web of Science ®Google Scholar
• Chou FC, Shieh SJ, Sytwu HK. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur. J. Immunol.39(9), 2403–2411 (2009).
   PubMed Web of Science ®Google Scholar
• Li L, Yi Z, Wang B, Tisch R. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination. J. Immunol.183(7), 4809–4816 (2009).
   PubMed Web of Science ®Google Scholar
• Haase C, Yu L, Eisenbarth G, Markholst H. Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells. Clin. Exp. Immunol.160(3), 331–339 (2010).
   PubMed Web of Science ®Google Scholar
• Hoang PT, Park P, Cobb LJ et al. The neurosurvival factor humanin inhibits βcell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism59(3), 343–349 (2010).
   PubMed Web of Science ®Google Scholar
• Jayaraman S, Patel T, Patel V et al. Transfusion of nonobese diabetic mice with allogeneic newborn blood ameliorates autoimmune diabetes and modifies the expression of selected immune response genes. J. Immunol.184(6), 3008–3015 (2010).
   PubMed Web of Science ®Google Scholar
• Xia CQ, Chernatynskaya A, Lai Y, Campbell KA, Clare-Salzler MJ. Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice. Clin. Immunol.135(3), 374–383 (2010).
   PubMed Web of Science ®Google Scholar
• Vincent BG, Young EF, Buntzman AS et al. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. J. Immunol.184(8), 4196–4204 (2010).
   PubMed Web of Science ®Google Scholar
• Nishimura M, Yokoi N, Miki T et al. Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray. DNA Res.11(5), 315–323 (2004).
   PubMed Web of Science ®Google Scholar
• Koulmanda M, Bhasin M, Hoffman L et al. Curative and b cell regenerative effects of a1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl Acad. Sci. USA105(42), 16242–16247 (2008).
   PubMed Web of Science ®Google Scholar
• Tsai S, Shameli A, Yamanouchi J et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity32(4), 568–580 (2010).
   PubMed Web of Science ®Google Scholar